Label Changes for:
MS Contin (morphine sulfate) controlled-release tablets
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – May 2010
Less Frequently Observed Reactions
- malaise, thinking disturbances, vertigo